A clinician scientist at LTRI @sinaihealth studying GLP-1, diabetes, obesity and the gut endocrine system Proud 🇨🇦Not going anywhere Am 🇮🇱Chai

Toronto
Joined May 2011
How do GLP-1 meds improve liver health through #weightloss independent mechanisms? Here @ChusaGzlzRellan & colleagues identify Liver Sinusoidal Endothelial Cells as direct targets of semaglutide, linking LSECs to reduction of #inflammation #Fibrosis #MASH cell.com/cell-metabolism/abs…
7
48
2
153
17,362
Daniel J Drucker retweeted
GLP-1 peptides protect the gut from immune injury. Essential role of endogenous GLP-1 family peptides to reduce inflammation and restore mucosal integrity in the experimental model @DanielJDrucker @CellRepMed cell.com/cell-reports-medici…
22
94
5
409
35,206
This Friday 8 am @SinaiHealth @uoftmedicine in Toronto, the 2026 Burrow Lecture, 8 am, Professor @cevansmo #Diabetes #islets
1
4
22
2,094
Daniel J Drucker retweeted
SCOOP: Top researchers at Columbia, Stanford, and others thought they were elected to elite scientific societies alongside Nobel laureates. The catch? The organizations are a sham. I spent the last month investigating a massive academic scam, for @Nature nature.com/articles/d41586-0…
12
184
30
501
151,704
Here the authors identify the glucagon-PKA-PDE2A-NCLX signaling axis as a key metabolic rheostat integrating mitochondrial calcium dynamics with lipid homeostasis, providing a promising therapeutic target for MASLD @MolMetab sciencedirect.com/science/ar…
2
9
48
4,152
Daniel J Drucker retweeted
The GLP-1 drugs have evidence for beneficial impact— heart, kidney, liver, joints, immune system, and brain—that are independent of weight loss @Cell_Metabolism @DanielJDrucker cell.com/cell-metabolism/abs…
40
272
16
1,142
149,364